Article
STING agonist-mediated endothelial cell activation drives NK cells and neutrophils-dependent pulmonary inflammation
2026-03-12
Abstract excerpt
Stimulator of interferon genes (STING) agonists and derivative molecules have been extensively developed for tumor immunotherapy. However, systemic exposure toxicity risks have constrained clinical trial progression and even threatened patient lives. Currently, systematic toxicity assessments for STING agonists remain lacking, with the mode of action for major organ injury yet to be elucidated. Here, we focused on...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a236cd90-4df8-5a85-8250-ead5eaa8395a
- DOI
- 10.64898/2026.03.10.710764
